CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 242 filers reported holding CONMED CORP in Q3 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,691,089 | +4.1% | 16,767 | +40.3% | 0.00% | -33.3% |
Q2 2023 | $1,624,291 | +21.9% | 11,952 | -6.8% | 0.00% | 0.0% |
Q1 2023 | $1,332,130 | +39.9% | 12,823 | +19.3% | 0.00% | +50.0% |
Q4 2022 | $952,382 | +4.3% | 10,751 | -5.7% | 0.00% | 0.0% |
Q3 2022 | $913,000 | -0.7% | 11,396 | +18.8% | 0.00% | 0.0% |
Q2 2022 | $919,000 | -49.8% | 9,593 | -6.5% | 0.00% | -50.0% |
Q1 2022 | $1,829,000 | +30.6% | 10,257 | +3.9% | 0.00% | +33.3% |
Q4 2021 | $1,400,000 | +31.6% | 9,874 | +21.5% | 0.00% | +50.0% |
Q3 2021 | $1,064,000 | +8.1% | 8,130 | +13.6% | 0.00% | 0.0% |
Q2 2021 | $984,000 | +8.4% | 7,157 | +3.0% | 0.00% | 0.0% |
Q1 2021 | $908,000 | +42.1% | 6,948 | +21.7% | 0.00% | 0.0% |
Q4 2020 | $639,000 | -17.5% | 5,707 | -41.9% | 0.00% | 0.0% |
Q3 2020 | $775,000 | +37.9% | 9,829 | +26.3% | 0.00% | 0.0% |
Q2 2020 | $562,000 | +23.8% | 7,784 | -1.8% | 0.00% | 0.0% |
Q1 2020 | $454,000 | – | 7,928 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |